Clinical trials
Angina, Unstable trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| CID - Carbostent & Implantable Devices | 2 |
| Ablynx, a Sanofi company | 1 |
| Antwerp Cardiovascular Institute Middelheim | 1 |
| Biopure Corporation | 1 |
| CeloNova BioSciences, Inc. | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Janssen Research & Development, LLC | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Maastricht University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina, Unstable | 20 |
| Myocardial Infarction | 10 |
| Acute Coronary Syndrome | 9 |
| Angina, Stable | 8 |
| Coronary Artery Disease | 7 |
| Non-ST Elevated Myocardial Infarction | 4 |
| Angina Pectoris | 3 |
| Myocardial Ischemia | 2 |
| Angina Pectoris, Variant | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.